NL6603256A - - Google Patents

Info

Publication number
NL6603256A
NL6603256A NL6603256A NL6603256A NL6603256A NL 6603256 A NL6603256 A NL 6603256A NL 6603256 A NL6603256 A NL 6603256A NL 6603256 A NL6603256 A NL 6603256A NL 6603256 A NL6603256 A NL 6603256A
Authority
NL
Netherlands
Application number
NL6603256A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL129434D priority Critical patent/NL129434C/xx
Application filed filed Critical
Priority to NL6603256A priority patent/NL6603256A/xx
Priority to US619867A priority patent/US3534041A/en
Priority to ES337526A priority patent/ES337526A1/es
Priority to DE1695556A priority patent/DE1695556C3/de
Priority to DE1795836A priority patent/DE1795836C2/de
Priority to GB01168/67A priority patent/GB1173783A/en
Priority to CH353167A priority patent/CH501647A/de
Priority to FI670729A priority patent/FI51694C/fi
Priority to DK128567AA priority patent/DK124824B/da
Priority to BE695304D priority patent/BE695304A/xx
Priority to BR187719/67A priority patent/BR6787719D0/pt
Priority to GR670137262A priority patent/GR37262B/el
Priority to SE03430/67A priority patent/SE331999B/xx
Priority to FR98531A priority patent/FR6764M/fr
Publication of NL6603256A publication Critical patent/NL6603256A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL6603256A 1966-03-12 1966-03-12 NL6603256A (tr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
NL129434D NL129434C (tr) 1966-03-12
NL6603256A NL6603256A (tr) 1966-03-12 1966-03-12
US619867A US3534041A (en) 1966-03-12 1967-03-01 Polycyclic piperazines
ES337526A ES337526A1 (es) 1966-03-12 1967-03-03 Un procedimiento para la manufactura de nuevas piperazinas.
DE1695556A DE1695556C3 (de) 1966-03-12 1967-03-09 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DE1795836A DE1795836C2 (de) 1966-03-12 1967-03-09 3-MethyI-2,3,4,4a-tetrahydro-lH- pyrazine [1,2-f] phenanthridin
GB01168/67A GB1173783A (en) 1966-03-12 1967-03-09 New Biologically Active Derivatives of Piperazine and Process for manufacture thereof
CH353167A CH501647A (de) 1966-03-12 1967-03-10 Verfahren zur Herstellung von Piperazinderivaten
FI670729A FI51694C (fi) 1966-03-12 1967-03-10 Menetelmä uusien farmaseuttisesti arvokkaiden piperatsiinien ja niiden happoadditiosuolojen valmistamiseksi
DK128567AA DK124824B (da) 1966-03-12 1967-03-10 Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf.
BE695304D BE695304A (tr) 1966-03-12 1967-03-10
BR187719/67A BR6787719D0 (pt) 1966-03-12 1967-03-10 Processo para a preparacao de novas piperazinas
GR670137262A GR37262B (el) 1966-03-12 1967-03-11 Μεθοδος δια την παρασκευην νεων βιολογικως ενεργων παραγωγων της πιπεραζινης.
SE03430/67A SE331999B (tr) 1966-03-12 1967-03-13
FR98531A FR6764M (tr) 1966-03-12 1967-03-13

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6603256A NL6603256A (tr) 1966-03-12 1966-03-12

Publications (1)

Publication Number Publication Date
NL6603256A true NL6603256A (tr) 1967-09-13

Family

ID=19795968

Family Applications (2)

Application Number Title Priority Date Filing Date
NL129434D NL129434C (tr) 1966-03-12
NL6603256A NL6603256A (tr) 1966-03-12 1966-03-12

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL129434D NL129434C (tr) 1966-03-12

Country Status (13)

Country Link
US (1) US3534041A (tr)
BE (1) BE695304A (tr)
BR (1) BR6787719D0 (tr)
CH (1) CH501647A (tr)
DE (2) DE1795836C2 (tr)
DK (1) DK124824B (tr)
ES (1) ES337526A1 (tr)
FI (1) FI51694C (tr)
FR (1) FR6764M (tr)
GB (1) GB1173783A (tr)
GR (1) GR37262B (tr)
NL (2) NL6603256A (tr)
SE (1) SE331999B (tr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070060A1 (tr) * 1968-10-15 1971-09-10 Sumitomo Chemical Co
EP0891350A1 (en) * 1996-04-03 1999-01-20 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US7700597B2 (en) 2004-12-03 2010-04-20 Schering Corporation Substituted piperazines as CB1 antagonists
US7897601B2 (en) 2006-01-18 2011-03-01 Intervet, Inc. Cannabinoid receptor modulators
US8623873B2 (en) 2007-06-28 2014-01-07 Intervet Inc. Substituted piperazines as CB1 antagonists

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL179906C (nl) * 1974-02-09 1986-12-01 Akzo Nv Werkwijze voor het bereiden van 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino (1,2-a)azepine derivaten.
US4217452A (en) * 1974-02-09 1980-08-12 Akzona Incorporated Synthesis for the preparation of tetracyclic compounds
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4128641A (en) * 1975-07-31 1978-12-05 Hzi Research Center Inc. Tetracyclic psychotropic drug
NL7610942A (nl) * 1976-10-02 1978-04-04 Akzo Nv Werkwijze voor het bereiden van 1,4-diazepine derivaten.
NL7809726A (nl) * 1978-09-26 1980-03-28 Akzo Nv Nieuwe tetracyclische verbindingen.
EP0055546B1 (en) * 1980-12-31 1984-08-01 Beecham Group Plc Pentacyclic compounds, processes for their preparation and their use
EP0088575B1 (en) * 1982-03-05 1986-12-30 Beecham Group Plc Pentacyclic compounds
EP0090552A3 (en) * 1982-03-27 1984-04-25 Beecham Group Plc Pentacyclic compounds
EP0126343A1 (en) * 1983-05-18 1984-11-28 Beecham Group Plc Treatment of diarrhoea
DE3472678D1 (de) * 1983-07-18 1988-08-18 Beecham Group Plc Benzazepine and benzoxazepine derivatives
EP0379483B1 (en) * 1987-04-10 1999-12-29 Monash University 1,2,3,4,10,14b-HEXAHYDRODIBENZO c,f]PYRAZINO- 1,2-a]AZEPINO DERIVATIVES
US5015738A (en) * 1989-08-07 1991-05-14 Hoechst-Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
US5189161A (en) * 1989-08-07 1993-02-23 Hoechst Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
ES2064887T3 (es) 1990-09-13 1995-02-01 Akzo Nobel Nv Composiciones quimicas solidas estabilizadas.
WO1999016769A1 (en) * 1997-09-26 1999-04-08 Monash University Resolution of optically-active compounds
US6548522B1 (en) 1999-10-12 2003-04-15 Hoffmann-La Roche Inc. Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US6723445B2 (en) 2001-12-31 2004-04-20 Canon Kabushiki Kaisha Organic light-emitting devices
AU2004271800A1 (en) 2003-09-12 2005-03-24 Pfizer Inc. Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
CA2614289A1 (en) * 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP2218442A1 (en) 2005-11-09 2010-08-18 CombinatoRx, Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
EP2125017A2 (en) * 2007-01-11 2009-12-02 Braincells, Inc. Modulation of neurogenesis with use of modafinil
WO2009128058A1 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
WO2010013240A1 (en) 2008-07-31 2010-02-04 Dekel Pharmaceuticals Ltd. Compositions and methods for treating inflammatory disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004975A (en) * 1961-10-17 Cochs
US3005789A (en) * 1955-10-11 1961-10-24 Gen Aniline & Film Corp Drier composition
US3151116A (en) * 1961-11-03 1964-09-29 Ciba Geigy Corp Certain 2-aza-indolo [2, 3-alpha] quinolizine compounds
US3328396A (en) * 1961-11-09 1967-06-27 Sterling Drug Inc 3, 8-di-substituted-3, 8-diazabicyclo [3.2.1] octanes
US3196154A (en) * 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3317524A (en) * 1965-02-04 1967-05-02 American Home Prod Substituted 1, 2, 3, 4-tetrahydro-pyrazino[1, 2-a]indoles
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070060A1 (tr) * 1968-10-15 1971-09-10 Sumitomo Chemical Co
EP0891350A1 (en) * 1996-04-03 1999-01-20 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0891350A4 (en) * 1996-04-03 2001-01-17 Merck & Co Inc FARNESYLE PROTEIN TRANSFERASE INHIBITORS
US7700597B2 (en) 2004-12-03 2010-04-20 Schering Corporation Substituted piperazines as CB1 antagonists
US8236805B2 (en) 2004-12-03 2012-08-07 Intervet Inc. Substituted piperazines as CB1 antagonists
US7897601B2 (en) 2006-01-18 2011-03-01 Intervet, Inc. Cannabinoid receptor modulators
US8623873B2 (en) 2007-06-28 2014-01-07 Intervet Inc. Substituted piperazines as CB1 antagonists

Also Published As

Publication number Publication date
GB1173783A (en) 1969-12-10
DE1795836B1 (de) 1977-11-24
DE1695556A1 (de) 1972-01-20
FI51694B (tr) 1976-11-30
US3534041A (en) 1970-10-13
GR37262B (el) 1969-05-10
FI51694C (fi) 1977-03-10
ES337526A1 (es) 1968-03-01
BR6787719D0 (pt) 1973-12-26
SE331999B (tr) 1971-01-25
DE1695556B2 (de) 1980-10-30
DE1695556C3 (de) 1981-06-25
NL129434C (tr)
DE1795836C2 (de) 1978-07-20
FR6764M (tr) 1969-03-10
DK124824B (da) 1972-11-27
CH501647A (de) 1971-01-15
BE695304A (tr) 1967-09-11

Similar Documents

Publication Publication Date Title
FI51694B (tr)
AT281852B (tr)
AU5917865A (tr)
AU428063B2 (tr)
AU424443B2 (tr)
AU421822B2 (tr)
AU417216B2 (tr)
AU414526B2 (tr)
AU415165B1 (tr)
AU433222B2 (tr)
AU218666A (tr)
AU6703465A (tr)
AU612166A (tr)
AU5895065A (tr)
AU1111066A (tr)
AU1144366A (tr)
AU414093B2 (tr)
BE447356A (tr)
AU855865A (tr)
AU2390066A (tr)
AU1027866A (tr)
AU433620A (tr)
AU411645B2 (tr)
BE692777A (tr)
AU407778B2 (tr)